Long Term Bio
Long only, biotech, healthcare, short only

Novavax: A Biotech Story Set To Double In 2014

There is a biotech company known as Novavax (NASDAQ:NVAX) that is creating vaccines for today's infectious diseases. This company has developed two different technology systems to create vaccines quickly, and efficiently for patients that need treatment immediately. The company is headquartered in Rockville Maryland, and was founded back in 1987. It has taken quite some time for this company to perfect its technology system, but it seems that it may have finally found the right formula to combat these infectious diseases.

Two Distinct Nanoparticle Technologies

  1. Virus-like Particles (VLPs)
  2. Recombinant protein micelles

Virus-like particles are engineered by the scientists at Novavax far differently than the current vaccines out on the market today. The current vaccines rely on killed viruses...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details